AMCP Regulatory NewsBreaks

Nov. 2, 2022: CMS Issues Final Rule on Part B Immunosuppressive Drug Benefit

The Medicare Program; Implementing Certain Provisions of the Consolidated Appropriations Act, 2021 and other Revisions to Medicare Enrollment and Eligibility Rules final rule implements certain provisions of the Consolidated Appropriations Act, 2021 (CAA) (P.L. 116-260) and is expected to be published in the Federal Register on Nov. 3, 2022.
PopHealth Week Logo

Meet Dr. Eddie Martucci Co-founder & CEO Akili

On today's episode of PopHealth Week, our guest is Eddie Martucci, PhD, co-founder & CEO of Akili Interactive, a company getting to the root of cognitive impairment by creating personalized digital therapeutics engineered to directly improve cognitive impairments.
Disease State Resource Center

Disease State Resources

Get in-depth information and explore up-to-date resources about pressing disease states in AMCP’s Disease State Resource Center. AMCP is pleased to work with leading pharmaceutical companies to offer these timely resources to you.